Clinical signs (e.g. muscle weakness) and serum creatine kinase (sCK) are useful markers of disease activity, but interpretation can be difficult (due to pain, fatigue, disease damage) and sCK can be normal in patients with IIM, mostly in patients with DM [2, 3]. This evidence concerns the gene SHC2 and dermatomyositis.